Introduction
============

Cancer is presently responsible for about 25% of deaths in developed countries and for 15% of all deaths worldwide ([@B01]). It is therefore considered one of the foremost health problems, with about 1.45 million new cancer cases expected yearly ([@B02],[@B03]). Antitumor chemotherapy is a very active field of research, and a large amount of information on the topic is generated every year ([@B04],[@B05]). However, there is a clear need for new treatments, from the medicinal chemistry and drug design point of view ([@B06]).

In recent years, aromatic multi-carboxylate acid compounds have been widely used as versatile ligands involved in various metal chelation reactions to form transition metal complexes with interesting properties in material sciences and biological systems ([@B07],[@B08]). These complexes can be easily synthesized from simple starting materials, where the metal ions, ligands, and coordination modes are the important factors for the self-assembly processes ([@B09],[@B10]). 1,3,5-benzenetrisbenzoic acid is a versatile ligand, which acts as monodentate or bridging group with end-on or end-to-end coordination mode to form complexes with interesting structures.

In this work, two new ***kgd***-type 2D bilayer and pillar-layered coordination polymers, namely {\[Mg~3~(BTB)(DMA)~4~\](DMA)~2~}~n~ (**1**) and {(H~2~NMe~2~)~2~\[Zn~3~(BTB)~2~(OH)(Im)\](DMF)~9~(MeOH)~7~}~n~ (**2**), were obtained ([Figure 1](#f01){ref-type="fig"}) and their anticancer activity was evaluated.

![Schematic representation of the H~3~BTB and Im ligands used in this research.](1414-431X-bjmbr-1414-431X20176929-gf01){#f01}

Material and Methods
====================

Apparatus and materials
-----------------------

All starting materials and reagents used in this research were obtained commercially and used without further purification. To obtain infra-red (IR) spectra (400∼4000 cm^-1^), we used a Brucker Equinox-55 spectrophotometer (Bruker, Germany). Element analyses (C, H, and N) were determined with a Vairo EL III analyzer (Elementar, Germany). Single crystal X-ray diffraction was carried out by an Oxford Xcalibur E diffractometer (Bruker Optics, Germany). A XT-4 micro melting apparatus (Ledon, China) was used to determine the melting points, and the thermometer remained uncorrected.

Synthesis and characterization of complexes 1 and 2
---------------------------------------------------

A mixture of Mg(NO~3~)~2~·6H~2~O (25.6 mg, 0.1 mmol), H~3~BTB (24.3 mg, 0.05 mmol), and DMA/H~2~O/CH~3~CN (V/V/V = 2/1/1, 5 mL) was sealed in a Teflon-lined stainless-steel vessel (20 mL), and heated to 120°C in 12 h, kept at 120°C for 3 days then slowly cooled to room temperature in 24 h. The colorless block crystals were collected, washed with DMF, and air dried. Details are as follows: Yield: 25.3 mg, 36% (based on H~3~BTB ligand). Mp. \>300°C. IR (KBr pellets) cm^-1^: 3440 (w), 2933 (w), 2433 (w), 1652 (w), 1103 (w), 930 (s), 810 (w), 682 (w), 597 (m). Elemental analysis for the framework of **1** (C~51~H~69~Mg~3~N~6~O~12~) was: C=59.23; H=6.44; N=8.29%. Calculated: C=59.41; H=6.75; N=8.15%.

A mixture of Zn(NO~3~)~2~·6H~2~O (0.1 mmol, 0.031 g), H~3~BTB (10 mg, 2.2 mmol) and imidazole (4.65 mg, 6.6 mmol) was added to a solution of MeOH (1 mL), H~2~O (2 mL), and DMF (2.5 mL) in a 25 mL Teflon-lined stainless steel container. The container was heated at 120°C for 48 h, and then cooled to room temperature at 2°C/min. The resulting material, in the form of light yellow single crystals, was washed with MeOH and left to air dry. Details are as follows: Mp. \>300°C. IR (KBr pellets) cm^-1^: 3134 (w), 2911 (w), 2410 (w), 1732 (w), 1143 (w), 976 (s), 808 (w), 689 (w), 590 (m). Analytical results found for compound **2** (C~137~H~178~N~21~O~36~Zn~6~) were: C=53.45; H=5.44; N=9.21%. Calculated: C=53.30; H=5.81; N=9.53%.

Crystal structure determination
-------------------------------

Suitable single crystals of compounds **1** and **2** were carefully selected under optical microscope and glued on thin glass fibers. The intensity data of **1** and **2** was obtained on an Oxford Xcalibur E diffractometer. The empirical absorption corrections were applied to the data using the SADABS system. This structure was solved by direct method and refined by full-matrix least-squares method on *F* ^2^ using the SHELXS--97 program ([@B11]). All non-hydrogen atoms of **1** and **2** were refined anisotropically, and all the hydrogen atoms attached to carbon atoms were fixed at their ideal positions. Pertinent crystal data and structural refinement results for compounds **1** and **2** are summarized in [Table 1](#t01){ref-type="table"}.

Table 1.Crystal data and structure refinements for compounds **1** and **2.**12FormulaC~19.50~H~21~Mg~0.75~N~1.50~O~4.5~C~99~H~71~N~10~O~20~Zn~6~*M*r366.612112.87Temperature/K293 (2)293 (2)Crystal systemMonoclinicMonoclinicSpace group*P*2~1~/*nP*2~1~/*ca*/Å12.4947 (4)24.3437 (8)*b*/Å25.7603 (9)28.0222 (6)*c*/Å13.7797 (5)19.8450 (4)*α*/°9090*β*/°99.622 (3)102.182 (3)*γ*/°9090*V*/Å^3^4372.8 (3)13232.7 (6)*Z*84*D* ~calc~/g·cm^-3^1.1141.061*μ*(Mo Kα)/mm^-1^0.0981.647*θ* range/°2.999 to 24.9993.594 to 73.853Reflections collected1555452557No. unique data \[*R*(int)\]7224 \[0.0347\]26073 \[0.0249\]No. data with *I* ≥ 2*σ*(*I*)492421300*R* ~1~0.06810.0430*ωR* ~2~(all data)0.19390.1320CCDC15610611561062

Antitumor activity
------------------

Four human liver cancer cells (HB611, HHCC, BEL-7405 and SMMC-7721) were grown in a RPMI 1460 medium supplemented with 10% fetal calf serum, 100 μg/mL penicillin and 100 μg/mL streptomycin. Cells were incubated at the temperature of 37°C in a moist incubator with 95% air and 5% CO~2~. Cells at exponential growth were diluted to 5×10^4^ cells/mL with RPMI1640, and then seeded on 96-well plates at a volume of 100 μL per well, and incubated for 24 h at 37°C in 5% CO~2~. After incubation of cells for up to 96 h, the medium was removed from each cell and 150 μL of MTT (0.5 mg/mL) solution, diluted 10-fold by RPMI 1460 was subsequently added. The IC~50~ values were measured by depicting the ratio viability versus concentration on a logarithmic chart and obtaining the concentration where 50% of cells were inhibited. In order to get mean values, each experiment was conducted at least three times in the same way.

Results and Discussion
======================

Molecular structure
-------------------

As shown in [Figure 2A](#f02){ref-type="fig"}, the asymmetric unit of **1** contains two crystallographically independent Mg(II) with 1/2 (Mg1) and 1 (Mg2) occupancies, one BTB^3-^ ligand, two coordinated DMA and one lattice DMA molecule. Both Mg1 and Mg2 reveal similar six-coordinated octahedral geometries. Mg1 is located at an inversion center of (-1/2, 0, 1/2) and surrounded by six carboxylate O atoms from six different BTB ligands with the Mg--O lengths ranging from 2.021(2) to 2.037(2) Å. Mg2 is coordinated by four carboxylate O atoms from three BTB^3-^ ligands and two O atoms from two coordinated DMA molecules with the Mg--O lengths in the range of 2.031(2)--2.203(3) Å. With the aid of a bridged carboxylate, two symmetry-related Mg2 ions and one Mg1 ion are held together to generate a \[Mg~3~(COO)~6~\] congregation ([Figure 2B](#f02){ref-type="fig"}). Due to the restriction of the terminal solvent molecules of Mg2, only a discrete \[Mg~3~(COO)~6~\] subunit is achieved. These trimeric clusters are further extended by BTB^3-^ ligands along the *ab* plane to give a 2D bilayer pattern ([Figure 2C](#f02){ref-type="fig"}). The Mg2⋯Mg2 distance in the linearly arranged Mg~3~ array is about 7.199 (2) Å, which is long enough to accommodate the bilayer network. These 2D bilayers adopt a parallel stacking arrangement to afford a 3D supramolecular architecture without classic H-bonding or pi-pi interaction. Topologically, the Mg~3~ SBUs and BTB ligands can be regarded as 6- and 3-connected nodes, respectively, and afford a binodal (3,6)-connected ***kgd*** network with the point symbol of {4^3^}~2~{4^6^·6^6^·8^3^} ([Figure 2D](#f02){ref-type="fig"}).

![*A*, View of the asymmetric unit of **1**; *B*, view of the \[Mg~3~(COO)~6~\] subunit of **1** (symmetry code A: 2-X, 1-Y, 2-Z); *C*, view of the 2D bi-layered structure of **1**; *D*, the binodal (3, 6)-connected ***kgd*** network for **1**.](1414-431X-bjmbr-1414-431X20176929-gf02){#f02}

The structural analysis results indicate that compound **2** crystallizes in the monoclinic space group P2~1~/c, and shows a 2-fold interpenetrated network. The asymmetric unit of **2** consists of six Zn(II) ions, three BTB^3^-ligands, five deprotonated Im ligands, two coordinated DMF molecules, and two lattice disordered H~2~NMe~2~ cations. The six Zn(II) ions exhibit two different coordinating modes ([Figure 3A](#f03){ref-type="fig"}): Zn1, Zn2, Zn4 and Zn5 atoms are four-coordinated by three O atoms from three different carboxylic acid groups on the BTB^3-^ ligands and one N atom from the deprotonated Im ligand, forming a distorted tetrahedral coordination mode; atoms Zn3 and Zn6 are five-connected by one(two) N atom(s) from the Im ligand(s) and three(two) O atoms from the carboxylic acid groups, resulting in a pyrometric geometry. Zn1-Zn6, Zn2-Zn3 and Zn4-Zn5 atoms are linked by the carboxylic groups to afford the binuclear Zn secondary building units (SBUs), which are joined by the Im pillars along the *c* axis to give rise to the 1D SBU chains ([Figure 3B](#f03){ref-type="fig"}). In addition, the BTB^3-^ ligand links with the binuclear Zn SBUs along *bc* plane to give the 6^3^ layer, and the Im ligands act as pillars between 2D sheets to form the three-dimensional (3D) framework. Due to its large solvent-accessible volume, such a framework might be large enough to accommodate another identical one to be interpenetrated, thus forming a doubly interpenetrated 3D framework with one-dimensional (1D) channel ([Figure 3C](#f03){ref-type="fig"}). Notably, the 1D channels are decorated with Im groups, which might be favorable for the formation of a H-bond interaction. The calculated void space per unit cell for guest-free framework is 40% as revealed by the PLATON analysis \[probe radius: 1.4 Å\]. From the topological point of view, the 3D structure of **2** can be rationalized as a 2-fold interpenetrated **hms**-type (3,5)-connected network by considering the BTB^3-^ ligand, binuclear Zn unit and the Im pillar as a 3, 5 and 2-connected node. ([Figure 3D](#f03){ref-type="fig"}).

![*A*, View of the coordination modes of Zn(II) ions in **2**; *B*, view of 1D secondary building unit chains and the 3D pillared framework; *C*, view of the 2-fold interpenetrated 3D framework of **2**; *D*, the **hms**-type (3,5)-connected topology for **2.**](1414-431X-bjmbr-1414-431X20176929-gf03){#f03}

Anticancer activity
-------------------

The cytotoxicity of the title compounds **1** and **2**, reference drug carboplatin, organic ligands H~3~BTB and Im against HB611, HHCC, BEL-7405 and SMMC-7721 cell lines were evaluated by MTT assay, and the IC~50~ values derived from the experimental data are shown in [Table 2](#t02){ref-type="table"}. The two organic ligands were ineffective against all cell lines (IC~50~ \>100 μM). At this concentration, H~3~BTB and Im would exert high cytotoxicity against normal cells, thus we conclude that it did not exert inactivation towards these cell lines.

Table 2.Growth inhibitory effects of **1**, **2**, carboplatin, H~3~BTB and Im on HB611, HHCC, BEL-7405 and SMMC-7721 cancer cells.CompoundsIC~50~ (μM)HB611HHCCBEL-7405SMMC-7721H~3~BTB\>100\>100\>100\>100Im\>100\>100\>100\>100**1**20253032**2**26232735Carboplatin25302540

However, after the cancer cells were incubated in the presence of compounds **1** and **2** for 72 h, the IC~50~ values for the compound ranged from 20 to 35 μM, which is similar or even lower than that of carboplatin (25--40 μM), indicating that the title compounds **1** and **2** exhibited anticancer activity against these cell lines in different degrees.

According to the above-mentioned data, it can be concluded that compared with organic ligands H~3~BTB and Im, the anticancer activity of compounds **1** and **2** was more effective. However, additional studies are needed to define the mechanism underlying the antitumor activity of these compounds and evaluate their efficacy *in vivo*.
